Akonni Biosystems will work with Seegene to develop point-of-care and high-throughput screening assays for the diagnosis of infectious pathogens known to cause respiratory disease.

The companies plan to combine Akonni's TruArray gel-drop microarray platform with Seegene's Dual Priming Oligo, or DPO, multiplex PCR technology in a bid to deliver a low-cost molecular diagnostics system.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.